Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Executive Officer

Chief Commercial Officer

President & CEO

Chief Financial Officer

Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of rare metabolic diseases. The company's therapeutic candidates include pegtarviliase, a polyethylene glycol modified, which is in Phase I/II clinical trial for the treatment of patient with homocystinuria; and pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy for the treatment of Arginase 1 deficiency. In addition, its preclinical pipeline includes AGLE-325 for the treatment of cystinuria, as well as other research programs. The company was formerly known as Aeglea BioTherapeutics Holdings, LLC and changed its name to Aeglea BioTherapeutics, Inc. in March 2015. Aeglea BioTherapeutics, Inc. was founded in 2013 and is headquartered in Austin, Texas.

Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of ...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2023-11-24	Premium	acquired	Premium	Premium	Premium	-
2023-11-24	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2022-08-25	Premium	bought	Premium	Premium	Premium	-
2022-06-08	Premium	bought	Premium	Premium	Premium	Chief Commercial Officer
2022-03-16	Premium	bought	Premium	Premium	Premium	President & CEO
2022-03-15	Premium	bought	Premium	Premium	Premium	President & CEO
2022-03-14	Premium	bought	Premium	Premium	Premium	President & CEO
2022-03-11	Premium	bought	Premium	Premium	Premium	President & CEO
2022-03-11	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2021-12-13	Premium	bought	Premium	Premium	Premium	-
2021-12-10	Premium	bought	Premium	Premium	Premium	President & CEO
2021-12-10	Premium	bought	Premium	Premium	Premium	-
2021-12-09	Premium	bought	Premium	Premium	Premium	President & CEO
2021-12-09	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2021-12-09	Premium	bought	Premium	Premium	Premium	-
2021-10-20	Premium	gifted	Premium	Premium	Premium	President & CEO
2021-10-20	Premium	gifted	Premium	Premium	Premium	President & CEO
2021-10-18	Premium	gifted	Premium	Premium	Premium	President & CEO
2021-10-18	Premium	gifted	Premium	Premium	Premium	President & CEO
2021-10-14	Premium	gifted	Premium	Premium	Premium	President & CEO
2021-10-14	Premium	gifted	Premium	Premium	Premium	President & CEO
2021-08-18	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2021-08-17	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2021-08-16	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2020-04-30	Premium	bought	Premium	Premium	Premium	President & CEO

AGLE - Aeglea BioTherapeutics Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for AGLE